Vibrent Health CEO Praduman "PJ" Jain, who also serves as principal investigator of the NIH All of Us Research Program's Participant Technology Systems Center, joined Healthcare IT News Executive Editor Mike Miliard to talk about the All of Us program, why his company is working with NIH on the initiative, how to ensuring clinical trials represent a broader cross-section of society, and what recent FDA guidance on clinical trial diversity might accomplish.

Like what you hear? Subscribe to the podcast on Apple Podcasts, Spotify or Google Play!

Talking points:

• The National Institutes of Health's All of Us Research Program – where it is on its journey to building a cohort of 1 million participants

• Vibrent Health and how it's working on this initiative 

• FDA draft guidance from this past April, on enrolling more participants from underrepresented racial and ethnic populations in the U.S. into clinical trials

• Research inclusion goals in the All of Us program

• How diversity is defined, and why it's broader than race and ethnicity

• How technology and digital health tools can help boost clinical trial diversity

More about this episode:

NIH All of Us program gearing up for 'precision engagement,' Eric Dishman says

NIH All of Us program makes more COVID-19 data available

NIH All of Us Research Program puts focus on precision nutrition

One man's quest to rid health IT investing of systemic racial and gender bias

AWS teams with THREAD for AI-enabled clinical trials management

Integrating tech to improve clinical trial recruitment

Castor is working to democratize clinical trials

Why diversity in clinical trials is crucial

Twitter: @MikeMiliardHITN
Email the writer: mike.miliard@himssmedia.com
Healthcare IT News is a HIMSS publication.